rs397516319
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_Strong
The NM_000260.4(MYO7A):c.5528T>G(p.Leu1843Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000005 in 1,599,160 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.5528T>G | p.Leu1843Arg | missense_variant | Exon 40 of 49 | 1 | NM_000260.4 | ENSP00000386331.3 | ||
MYO7A | ENST00000458637.6 | c.5414T>G | p.Leu1805Arg | missense_variant | Exon 40 of 49 | 1 | ENSP00000392185.2 | |||
MYO7A | ENST00000409619.6 | c.5381T>G | p.Leu1794Arg | missense_variant | Exon 41 of 50 | 1 | ENSP00000386635.2 | |||
MYO7A | ENST00000458169.2 | c.2954T>G | p.Leu985Arg | missense_variant | Exon 20 of 29 | 1 | ENSP00000417017.2 | |||
MYO7A | ENST00000670577.1 | n.*126T>G | non_coding_transcript_exon_variant | Exon 23 of 32 | ENSP00000499323.1 | |||||
MYO7A | ENST00000670577 | n.*126T>G | 3_prime_UTR_variant | Exon 23 of 30 | ENSP00000499323.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152118Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000484 AC: 7AN: 1447042Hom.: 0 Cov.: 32 AF XY: 0.00000696 AC XY: 5AN XY: 718414
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152118Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74308
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Pathogenic. The Leu1843Arg variant in MYO7A has not been reported in the literature nor previously identifi ed by our laboratory. This residue is conserved across species and computational analyses (biochemical amino acid change, homology, PolyPhen2, SIFT) suggest tha t the Leu1843Arg variant may impact the protein. However, this information is no t predictive enough to assume pathogenicity. The presence of this variant in com bination with a pathogenic MYO7A variant and in an individual with clinical feat ures of hearing loss, increases the likelihood that the Leu1843Arg variant is pa thogenic. However, it should be noted that this lab has only sequenced MYO7A in 22 Black probands and no Black healthy controls. In addition, healthy control in formation is limited in either public databases or scientific literature, such t hat the full spectrum of benign variation has not yet been defined for this gene . Future analysis could reveal that the Leu1843Arg variant is common in this pop ulation and therefore unlikely to be pathogenic. In summary, the clinical signif icance of this variant cannot be determined with certainty at this time. -
Inborn genetic diseases Uncertain:1
The c.5528T>G (p.L1843R) alteration is located in exon 40 (coding exon 39) of the MYO7A gene. This alteration results from a T to G substitution at nucleotide position 5528, causing the leucine (L) at amino acid position 1843 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Usher syndrome type 1B Uncertain:1
- -
not provided Uncertain:1
This sequence change replaces leucine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 1843 of the MYO7A protein (p.Leu1843Arg). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with MYO7A-related conditions. ClinVar contains an entry for this variant (Variation ID: 43285). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt MYO7A protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at